Susceptibility to meningitis pinpointed

by Jeffrey Bigongiari on August 19, 2010

Meningitis

Meningitis

There are genetic differences that make some people susceptible to meningococcal meningitis and septicemia and leave others immune, according to recently released research.

Meningitis vaccine breakthrough

by Ashton Daigle on August 9, 2010

Meningitis

Meningitis

Medical researchers in London and Singapore say they might have discovered a breakthrough in finding a vaccine for one of the most fatal strains of meningitis.

Trovan lawsuit stalls

by Tina Redlup on July 26, 2010

Vaccine

A lawsuit filed by the Nigerian victims of the 1996 Trovan meningitis vaccine test hit a snag after officials with Federal High Court in Abuja, Nigeria, set aside the service of the court’s processes on Pfizer Specialties.

Pfizer sued for $384 billion over 1996 meningitis trials

by Ashton Daigle on July 22, 2010

Meningitis_virus

Meningitis

Nigerian victims of the 1996 Pfizer meningitis Trovan vaccine test announced July 20 that they are suing the company for $384 billion.

New meningitis vaccine may stop outbreaks

by Ashton Daigle on July 2, 2010

Meningitis

Meningitis

The development of a new meningitis vaccine may help prevent epidemics in Africa for the first time.

FDA seeks additional GlaxoSmithKline meningitis vaccine data

by Ashton Daigle on June 15, 2010

Meningitisbacteria

Meningitis bacteria

Officials with GlaxoSmithKline have announced that the U.S. Food and Drug Administration has requested more information about the company’s experimental meningitis vaccine, MenHibrix, before deciding if they will approve it.

Pfizer, Glaxo sign 10-year vaccine deal for poor

by Ted Purlain on March 24, 2010

Pneumococcal

Pneumococcal

LONDON — Pfizer and GlaxoSmithKline signed a landmark 10-year deal March 23 to supply 60 million doses a year of cut-price pneumococcal vaccines to developing nations.

Meningococcal disease outbreak in Okla. kills 2 children

by Pat Dulnier on March 22, 2010

Meningitis

Meningitis

In the wake of an outbreak of meningococcal disease at Oologah-Talala Public Schools, state and local health officials offered free vaccinations to the school system's students and staff, according to the Tulsa World.

EU approves Novartis’ Menveo for meningococcal disease

by Pat Dulnier on March 19, 2010

Meningitis

Meningococcal

BASEL, Switzerland — Novartis announced March 18 that the European Commission granted a marketing authorization for its vaccines against meningococcal disease.

Meningitis at OU now 'outbreak'

by Rita Uplend on March 9, 2010

Meningitis

Meningitis

COLUMBUS, Ohio — The seven bacterial meningitis cases at Ohio University the past two years have been declared an outbreak by the U.S. Centers for Disease Control and Prevention, The Columbus Dispatch reported March 7.

Meningitis outbreak kills 250 in Burkina Faso

by Rita Uplend on March 3, 2010

Malaria_mosquito

Health officials in the west African country of Burkina Faso are worried about an increase in deaths from meningitis which has killed about 250 people so far this year, up from 203 in the same period last year.

Pfizer factory in N.C. to help make new vaccine

by Rita Uplend on February 26, 2010

Pfizer

CHARLOTTE, N.C. — A new version of the Prevnar childhood vaccine that federal regulators approved Feb. 24 will be partly produced at the company's drug factory in Sanford.

Novartis receives FDA approval of Menveo

by Paul Tinder on February 25, 2010

Fda-logo

BASEL, Switzerland — The U.S. Food and Drug Administration approved Novartis’ Menveo to prevent meningococcal disease, which infects more than 500,000 people each year, leading to more than 50,000 deaths globally.

India’s health ministry to initiate impact study on pneumococcal conjugate vaccine

by Daniel Purt on December 26, 2009

Strep-pneumoniae

Streptococcus Pneumoniae

Along with rolling out the (five-in-one vaccine to check pneumonia as planned, the union health ministry will launch an impact study in one high-mortality state before deciding on introducing pneumococcal conjugate vaccine as part of the India’s national

EU agency recommends Novartis meningitis vaccine

by Tina Redlup on December 18, 2009

Fda-logo

ZURICH — Europe's drugs watchdog has recommended approving a meningitis vaccine made by Switzerland's Novartis, according to Reuters.